Alzheimer Society of Canada Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2006
NCT00376051
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Alzheimer Society of Canada

Active Ingredients

Drugs in Phase 4 Trials (1)

citalopram (celexa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aphasia, Primary Progressive (Phase 4)

Dementia (Phase 4)

Frontotemporal Dementia (Phase 4)

Pick Disease of the Brain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1